Please use this identifier to cite or link to this item:
Title: Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study
Authors: Samol, J
Ranson, M
Scott, E
Macpherson, E
Carmichael, J
Thomas, A
Cassidy, J
First Published: Aug-2012
Citation: INVESTIGATIONAL NEW DRUGS, 2012, 30 (4), pp. 1493-1500
DOI Link: 10.1007/s10637-011-9682-9
ISSN: 0167-6997
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.